Climate change and air pollution have been linked to the onset and aggravation of allergic rhinitis (hayfever). With modern lifestyles, we now spend approximately 90% of our time indoors. While this might seem like a lot, it includes time spent at home, work, school, restaurants, and other indoor environments.
You might assume that being indoors and away from outside pollutants means breathing cleaner air, but this isn’t always the case. Indoor air pollution—caused by mould spores, pet dander, dust mites, and emissions from cooking or cleaning—can significantly impact respiratory health. In fact, indoor air can contain up to ten times more pollutants than outdoor air, with bedrooms often having the poorest air quality.
Common Indoor Allergens
Dust mites are a major source of indoor allergens and pets the second largest source. Add to this mould spores, and the air quality in our homes could be brought into question.
Sometimes people mistake their allergy symptoms, such as sneezing and a runny nose, for a common cold, leading them to overlook the real cause.
How to Improve Indoor Air Quality
These steps can go a long way in creating a healthier indoor environment and assisting in reducing allergy symptoms caused by poor air quality.
IE-ZI-2500014
Zirtek Allergy Relief (6+) and Zirtek Oral Solution (2+) contain cetirizine dihydrochloride. Zirtek is for the relief from itchy watery eyes, blocked or runny nose and sneezing caused by hayfever and winter allergens such as dust, pets and moulds as well as allergic itchy skin rashes (hives).
Zirtek Plus Decongestant (12+) contains pseudoephedrine and cetirizine dihydrochloride. Zirtek Plus Decongestant is for the relief of symptoms such as blocked or runny nose, sneezing, and itchy eyes or nose associated with hayfever and airborne winter allergens such as dust, pets, and moulds.
Always read the label. For further allergy advice please contact your GP or Pharmacist.
Medical Disclaimer:
The information provided herein should not be used during any medical emergency, or for diagnosis or treatment of any medical condition. Please consult your doctor or pharmacist if you have any questions regarding your condition.
References are available upon request.
UCB (Pharma) Ireland Ltd
Email: ucbcares.ie@ucb.com
Telephone: +353 1 463 2371
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.
Adverse events should also be reported to UCB (Pharma) Ireland Ltd at ucbcares.ie@ucb.com or 1800 930075